Inflanor (Ibuprofen)

Ibuprofen works by inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for the synthesis of prostaglandins. By lowering prostaglandin levels, it reduces inflammation, diminishes pain signaling, and helps reset the hypothalamic temperature set‑point, thereby providing analgesic, antipyretic, and anti‑inflammatory effects.

The dose of Inflanor is determined by the prescribing healthcare professional based on the individual’s condition, age, weight, and overall health status. The prescriber will select the appropriate strength, frequency, and duration to achieve therapeutic benefit while minimizing risk.

Safety of ibuprofen in pregnancy and lactation has not been fully established. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and only under medical supervision. Women who are pregnant, especially in the third trimester, or who are breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the Inflanor product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements if applicable), and assists with import documentation.

Inflanor (ibuprofen) shares the core NSAID properties of analgesia, antipyresis, and anti‑inflammation with agents such as naproxen, diclofenac, and aspirin. Compared with some longer‑acting NSAIDs, ibuprofen has a relatively short half‑life, allowing flexible dosing but may require multiple daily administrations. Its safety profile is well‑characterized, though gastrointestinal and renal risks are comparable across the class.

Inflanor should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Inflanor is taken orally with a full glass of water. It may be taken with or without food; however, taking it with food or milk can reduce the likelihood of gastrointestinal discomfort. Swallow tablets whole; do not crush or chew unless specifically instructed by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulcer perforation, acute kidney injury, severe allergic reactions such as anaphylaxis, and increased cardiovascular events (e.g., heart attack or stroke) especially in patients with existing heart disease. Patients should seek immediate medical attention if they experience signs of bleeding, severe abdominal pain, sudden swelling, or difficulty breathing.

Inflanor should be avoided in individuals with known hypersensitivity to ibuprofen or any NSAID, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, the third trimester of pregnancy, and patients concurrently using anticoagulants without close monitoring. Consultation with a healthcare professional is essential before starting therapy in these situations.